What is the main business of Almega Pharma?

The main business activity of Almega Pharma focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 15, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Myślenicka 133A, 30-698 Kraków.

Who is on the management board?

The management board consists of: Vitalii Nelha (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $192,375 in 2024, which is an increase of 77.2% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $60,364.

What is the largest operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $79,632 in 2024, representing 63% of all operating expenses.

Almega Pharmasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-12-15

Share capital

50 000,00 PLN

Registered address

ul. Myślenicka 133A, 30-698 Kraków, Poland

Website

almegapharma.pl

Electronic delivery address

AE:PL-34126-54845-GFIDA-28

Financials

Revenue history (in k)

Filing timeliness

1 of 5 financial statements was filed late (for 2021, 66 days late).

2025filed
202414/07/2025
202302/07/2024
202230/06/2023
202119/09/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 221.33kMedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD 52.83kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 154.24kMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 179.97kMedianUSD 609.79kAverageUSD 11.85m

Industry

Authorized Representatives

Vitalii Nelha – President of the Management Board

Manner of representation

Each member of the management board has the right to represent the company independently.

Ownership

Owner	Shares	Share value	Stake
Robert Liwińskiage 49	50	$6,753.11	50%
Vitalii Nelhaage 48	50	$6,753.11	50%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2021-01-15.

ING Bank Śląski
05 1050 1445 1000 0090 3237 8540
ING Bank Śląski
27 1050 1445 1000 0090 3237 8532

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Eclipse Boluk-Sobolewskasp. k.	$10,235,697.61	eclipsemedical.pl
Passimedsp. z o.o.	$1,677,642.39	passimed.pl
Medimessp. z o.o.	$1,228,073.80	medimes.pl
Model MedicalS.A.	$754,014.76	modelmedical.pl
Interforum Pharmasp. z o.o.	$710,214.55	interforumpharma.com
Softmedicasp. z o.o.	$481,553.31	softmedica.com.pl
Eduaidsp. z o.o.	$22,952.22	eduaid.pl
Beyond Medical Aesthetics Polskasp. z o.o.	$13,696.94	bmapolska.pl
Focusmed Sp.Z O.O.sp. z o.o.	–	focusmed.pl
Model Medical Radiologiasp. z o.o.	–	modelmedical.pl